A032300 Share Price Performance
₩13,950.00
-2170.00 (-13.46%)
Price ₩13,950.00
Share Price₩13,950.00
KOREA PHARMA's (KOSDAQ:032300) Profits Appear To Have Quality Issues
May 23
KOREA PHARMA Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A032300 Community Narratives
There are no narratives available yet.
KOREA PHARMA Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 132.81
- Gross Margin
- 40.52%
- Net Profit Margin
- 1.70%
- Debt/Equity Ratio
- 50.7%
KOREA PHARMA Co., Ltd. Competitors
Snowflake Analysis
About A032300
- Founded
- 1974
- Employees
- n/a
- CEO
- WebsiteView website
KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.4%
- 3 Months: 13.2%
- 1 Year: 33.0%
- Year to Date: 44.6%
Over the last 7 days, the market has risen 3.3%, driven by gains of 7.1% in the Information Technology sector. As for the past 12 months, the market is up 33%. Looking forward, earnings are forecast to grow by 24% annually. Market details ›